Acquired RASopathic changes associated with BRAF-inhibitor treatment

Int J Dermatol. 2021 Jul;60(7):893-895. doi: 10.1111/ijd.15506. Epub 2021 Mar 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Humans
  • Mutation
  • Protein Kinase Inhibitors* / adverse effects
  • Proto-Oncogene Proteins B-raf* / genetics
  • Vemurafenib / adverse effects

Substances

  • Protein Kinase Inhibitors
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf